Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Med. & Reg. Officer
-
Stock Symbol
-
CPRX on Nasdaq
Gary Ingenito - trading volume in the past year for Catalyst Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Restricted Stock Units |
1.02M |
$2.27M |
$2.24 |
Feb 14, 2025 |
Direct |
Common Stock |
|
Common Stock, par value $0.001 per share |
68.9K |
$154K |
$2.24 |
Feb 14, 2025 |
Direct |
|
|
Options to purchase common stock |
1.05M |
|
|
Jun 5, 2024 |
Direct |
Common Stock |
|
Options to purchase common stock |
1.04M |
|
|
Nov 27, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.